Completely reversible agranulocytosis in a multiple myeloma patient treated with thalidomide-dexamethasone.
Magalini
Francesca
F
Stella
Adriano
A
Sansoni
Paolo
P
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced / Q000188:drug therapy*; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D003907:Dexamethasone / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects*
D020533:Angiogenesis Inhibitors; D018931:Antineoplastic Agents, Hormonal; D013792:Thalidomide; D003907:Dexamethasone